-
Symbol
-
JBIO on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
10.4M shares
-
Security Ownership
-
20%
Shares, Excluding Options vs Price
Value, Excluding Options
Fairmount Funds Management LLC ownership in Jade Biosciences, Inc. Common Stock, $0.0001 par value per share (JBIO)
2025-10-08 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.4M shares of Jade Biosciences, Inc. Common Stock, $0.0001 par value per share (JBIO).
This represents 20% percent ownership of the company.
In their previous filing dated 2025-05-01, Fairmount Funds Management LLC had reported owning 7.25M shares, indicating an increase of 42.8% percent.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.